Sarcoma PDX Models

Patient-derived xenograft (PDX) models provide a predictive preclinical model for the evaluation of an agents efficacy prior to entering the clinic. The CrownBio collection contains many sarcoma PDX models of both North American and Asian decent for a true representation of the variability found in the patient population. More

PDX offer the most translational preclinical model for efficacy screening in cancer drug development. Derived directly from patient tumors and never adapted to grow in vitro, PDX models reflect the heterogeneity and diversity of the human patient population. PDX give you an accurate, predictive model of how your treatment will perform, well before entering into expensive clinical trials. CrownBio’s HuPrime® PDX models are well characterized for pathology, growth characteristics, and are also genetically/genomically annotated for gene expression, gene copy number, mutations, and fusions.
MODEL NUMBER CANCER SUBTYPE # per page
SA0271 Spindle cell carcinomaCLICK TO VIEW
SA0319 Spindle cell carcinomaCLICK TO VIEW
SA0639 rhabdomyosarcomaCLICK TO VIEW
SA0666 Spindle cell carcinomaCLICK TO VIEW
SA10132 SarcomaCLICK TO VIEW
SA10139 clear cell sarcomaCLICK TO VIEW
SA10145 SarcomaCLICK TO VIEW
SA10146 NACLICK TO VIEW
SA10151 NACLICK TO VIEW
SA10153 SarcomaCLICK TO VIEW
SA10154 SarcomaCLICK TO VIEW
SA10157 LEIOMYOSARCOMACLICK TO VIEW
SA10159 synovial sarcomaCLICK TO VIEW
SA10160 LEIOMYOSARCOMACLICK TO VIEW
SA10162 NACLICK TO VIEW
SA10162 synovial sarcomaCLICK TO VIEW
SA10164 SarcomaCLICK TO VIEW
SA10166 SarcomaCLICK TO VIEW
SA10171 Soft Tissue SarcomaCLICK TO VIEW
SA10174 RHABDOMYOSARCOMACLICK TO VIEW